Skip to main content
logo
Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.660
-0.060 (-1.61%)
At close: Sep 18, 2026, 4:00 PM EDT
3.620
-0.040 (-1.09%)
After-hours: Sep 18, 2026, 7:50 PM EDT

Quantum BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
7.499.059.419.0314.4515.93
Research & Development
1.582.766.083.866.916.33
Operating Expenses
12.3115.316.1419.2327.4333.74
Operating Income
-12.31-15.3-16.14-19.23-27.43-33.74
Interest Expense
-1.81-2.11-0.05-0-0.05-0.07
Interest & Investment Income
0.080.240.570.790.370
Other Non Operating Income (Expenses)
-14.14-12.61-0.030.210.520.68
EBT Excluding Unusual Items
-28.18-29.78-15.64-18.24-26.59-33.13
Gain (Loss) on Sale of Investments
0.140.43-0-0.38-0.23-0.86
Asset Writedown
----4.56--
Legal Settlements
2.352.35----
Other Unusual Items
0.390.040.734.940.120.05
Pretax Income
-25.3-26.96-14.92-18.23-26.7-33.94
Earnings From Continuing Operations
-25.3-26.96-14.92-18.23-26.7-33.94
Earnings From Discontinued Operations
----3.1-1.35
Net Income to Company
-25.3-26.96-14.92-18.23-23.61-35.29
Minority Interest in Earnings
0.140.780.710.33--
Net Income
-25.16-26.18-14.2-17.9-23.61-35.29
Net Income to Common
-25.16-26.18-14.2-17.9-23.61-35.29
Net Income Growth
------
Shares Outstanding (Basic)
531111
Shares Outstanding (Diluted)
531111
Shares Change
114.18%189.01%86.67%2.21%10.84%190.15%
EPS (Basic)
-5.35-7.97-12.49-29.39-39.62-65.63
EPS (Diluted)
-5.35-7.97-12.49-29.39-39.62-65.63
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5.49-8.24-6.88-10.83-28.45-20.75
Free Cash Flow Per Share
-1.17-2.51-6.05-17.78-47.74-38.59
EBITDA
-11.78-14.76-15.65-16.73-22.9-29.7
D&A For EBITDA
0.530.550.492.514.534.05
EBIT
-12.31-15.3-16.14-19.23-27.43-33.74
SEC Filings: 10-K · 10-Q